Arrowhead Pharmaceuticals Inc Capital Reinvestment Ratio
Arrowhead Pharmaceuticals Inc capital reinvestment ratio. Arrowhead Pharmaceuticals Inc (ARWR) has a Capital Reinvestment Ratio of 0.37x as of September 2025, meaning it reinvests 0% of its operating cash flow ($20.49 Million) in capital expenditures ($7.49 Million). Check Arrowhead Pharmaceuticals Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Arrowhead Pharmaceuticals Inc (2019–2025)
Capital reinvestment ratio of Arrowhead Pharmaceuticals Inc from 2019 to 2025. This chart tracks Arrowhead Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore Arrowhead Pharmaceuticals Inc annual equity growth to track the company's year-over-year net asset growth rate.
Arrowhead Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2019–2025)
Arrowhead Pharmaceuticals Inc capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see how efficiently does Arrowhead Pharmaceuticals Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | $179.55 Million | $22.67 Million | ▼ -8.3% |
| 2021 | 0.14x | $171.22 Million | $23.57 Million | ▲ +98.4% |
| 2019 | 0.07x | $173.03 Million | $12.00 Million | — |